Zhang, Mang
Chen, Yu
Wu, Weili
Jin, Feng
Li, Yuanyuan
Long, Jinhua
Luo, Xiuling
Gong, Xiuyun
Chen, Xiaoxiao
Liu, Lina
Tang, Hong
Wang, Ziqi
Clinical trials referenced in this document:
Documents that mention this clinical trial
A prospective phase II randomized study of docetaxel combined with lobaplatin versus TPF regimen induction chemotherapy followed by concurrent chemoradiotherapy for locally advanced head and neck squamous cell carcinoma
https://doi.org/10.1007/s00432-023-05497-1
Funding for this research was provided by:
Qian Jiao He KY ([2017]038)
Qian Ke He Ji ([2017]1148)
Article History
Received: 6 August 2023
Accepted: 28 October 2023
First Online: 20 November 2023
Declarations
:
: The authors declare that they have no competing interests.
: The authors are accountable for all aspects of the work in ensuring that questions related to the accuracy or integrity of any part of the work are appropriately investigated and resolved. This study has been performed in accordance with the Declaration of Helsinki and has been approved by the Ethics Committee, the approval number is 2017-01, and all patients signed informed consent.
: Not applicable.